1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer
2021) In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 43(1). p.209-223(
- Contribution to journal › Article
- 2020
-
Mark
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer
(
- Contribution to journal › Article
-
Mark
Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis
(
- Contribution to journal › Article
- 2019
-
Mark
Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer
(
- Contribution to journal › Article
-
Mark
The chemokine CXCL16 is a new biomarker for lymph node analysis of colon cancer outcome
(
- Contribution to journal › Article
- 2018
-
Mark
Lymph node CXCL17 messenger RNA : A new prognostic biomarker for colon cancer
(
- Contribution to journal › Article
- 2017
-
Mark
The importance of rectal washout for the oncological outcome after Hartmann’s procedure for rectal cancer : analysis of population-based data from the Swedish Colorectal Cancer Registry
(
- Contribution to journal › Article
- 2013
-
Mark
Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997.
(
- Contribution to journal › Article
- 2012
-
Mark
Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
(
- Contribution to journal › Article